1217 — China Innovation Investment Income Statement
0.000.00%
Last trade - 00:00- HK$140.82m
- -HK$157.64m
- HK$20.26m
- 49
- 64
- 14
- 36
Annual income statement for China Innovation Investment, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | -3.64 | -26.7 | -2.07 | 9.51 | 20.3 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6.1 | 7.11 | -7.87 | 7.24 | 14.4 |
| Operating Profit | -9.75 | -33.8 | 5.8 | 2.27 | 5.82 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -9.81 | -33.9 | 5.76 | 2.19 | 5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -9.81 | -33.9 | 5.76 | 2.19 | 5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -9.81 | -33.9 | 5.76 | 2.19 | 5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -9.81 | -33.9 | 5.76 | 2.19 | 5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0.003 | 0 | 0 | 0 |